Overview

Protective Effects of Edaravone Dexborneol

Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The patients of acute ischemic stroke were divided into two groups, edaravone dexborneol treatment group and edaravone treatment group. The purpose of this study was to observe the changes of imaging and the improvement of NIHSS and mRS in different groups.
Phase:
N/A
Details
Lead Sponsor:
Lili Cao
Qianfoshan Hospital
Treatments:
Edaravone